Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Neurosurgery
|
February 16, 2002
Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy
E S Connolly, C J Winfree, A Rampersad, et al.
Neurology
|
August 24, 2005
Longitudinal volumetric MRI change and rate of cognitive decline
D Mungas, D Harvey, B R Reed, et al.
Climacteric : the Journal of the International Menopause Society
|
June 28, 2014
Prevention of diseases after menopause
R A Lobo, S R Davis, T J De Villiers, et al.
Annals of Internal Medicine
|
December 4, 2001
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial
H N Hodis, W J Mack, R A Lobo, et al.
Acta Neurochirurgica
|
June 25, 2008
Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following carotid endarterectomy
W J Mack, A F Ducruet, Z L Hickman, et al.
International Journal of HIV/AIDS and Research
|
March 27, 2018
Pharmacogenetic Associations with ADME Variants and Virologic Response to an Initial HAART Regimen in HIV-Infected Women
C L Pearce, D Stram, A Wiensch, et al.
Annals of Internal Medicine
|
November 15, 1993
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS)
D H Blankenhorn, S P Azen, D M Kramsch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2001
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
J Huang, D B Agus, C J Winfree, et al.
Cancer Causes & Control : CCC
|
January 5, 2000
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases
S Franceschi, S Preston-Martin, L Dal Maso, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 24, 2023
Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia
H N Yassine, I C Arellanes, A Mazmanian, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Neurosurgery
|
February 16, 2002
Serum S100B protein levels are correlated with subclinical neurocognitive declines after carotid endarterectomy
E S Connolly, C J Winfree, A Rampersad, et al.
Neurology
|
August 24, 2005
Longitudinal volumetric MRI change and rate of cognitive decline
D Mungas, D Harvey, B R Reed, et al.
Climacteric : the Journal of the International Menopause Society
|
June 28, 2014
Prevention of diseases after menopause
R A Lobo, S R Davis, T J De Villiers, et al.
Annals of Internal Medicine
|
December 4, 2001
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial
H N Hodis, W J Mack, R A Lobo, et al.
Acta Neurochirurgica
|
June 25, 2008
Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following carotid endarterectomy
W J Mack, A F Ducruet, Z L Hickman, et al.
International Journal of HIV/AIDS and Research
|
March 27, 2018
Pharmacogenetic Associations with ADME Variants and Virologic Response to an Initial HAART Regimen in HIV-Infected Women
C L Pearce, D Stram, A Wiensch, et al.
Annals of Internal Medicine
|
November 15, 1993
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS)
D H Blankenhorn, S P Azen, D M Kramsch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2001
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
J Huang, D B Agus, C J Winfree, et al.
Cancer Causes & Control : CCC
|
January 5, 2000
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases
S Franceschi, S Preston-Martin, L Dal Maso, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 24, 2023
Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia
H N Yassine, I C Arellanes, A Mazmanian, et al.
Page
of 10